Literature DB >> 1926033

Albendazole in the treatment of pulmonary echinococcosis.

P Aggarwal1, J P Wali.   

Abstract

Ten patients with pulmonary hydatid disease diagnosed on the basis of a chest radiograph and a positive response to the indirect haemagglutination test for hydatid disease were treated with albendazole 10 mg/kg/day for eight weeks. None of the 10 patients showed any radiological or serological improvement with this treatment regimen. Albendazole in these doses appears to have little role in the treatment of pulmonary hydatid disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926033      PMCID: PMC463292          DOI: 10.1136/thx.46.8.599

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance.

Authors:  U Steiger; J Cotting; J Reichen
Journal:  Clin Pharmacol Ther       Date:  1990-03       Impact factor: 6.875

2.  Serology in patients treated with albendazole for hydatid disease.

Authors:  M H Wilcox; D L Morris; J W Bailey
Journal:  J R Soc Med       Date:  1988-12       Impact factor: 5.344

3.  Albendazole in hydatid disease.

Authors:  D L Morris; P W Dykes; B Dickson; S E Marriner; J A Bogan; F G Burrows
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

4.  Treatment of pulmonary hydatid cyst with mebendazole.

Authors:  A Shivashankar; L H Lature; P S Shankar
Journal:  J Assoc Physicians India       Date:  1982-05

5.  Chemotherapy of Echinococcus infection in man with albendazole.

Authors:  R J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jan-Feb       Impact factor: 2.184

6.  Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis.

Authors:  A Davis; Z S Pawlowski; H Dixon
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Hydatid disease: research and control in Turkana, III. Albendazole in the treatment of inoperable hydatid disease in Kenya--a report on 12 cases.

Authors:  G B Okelo
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

8.  Albendazole treatment of human cystic echinococcosis.

Authors:  T Todorov; K Vutova; D Petkov; G Mechkov; K Kolev
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

9.  Albendazole--objective evidence of response in human hydatid disease.

Authors:  D L Morris; P W Dykes; S Marriner; J Bogan; F Burrows; H Skeene-Smith; M J Clarkson
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

10.  Albendazole treatment of recurrent hydatid disease: serial evaluation with ultrasound.

Authors:  D Cossetto; S Gruenewald; V Antico; J M Little
Journal:  Aust N Z J Surg       Date:  1989-12
  10 in total
  4 in total

1.  Diagnosis and treatment of pulmonary cystic hydatidosis.

Authors:  D Tatar; G Senol; E Gunes; S Unsal; G Perim
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

2.  Echinococcus of the liver.

Authors:  D L Morris
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

Review 3.  Treatment of hydatid disease.

Authors:  D Anadol; U Ozçelik; N Kiper; A Göçmen
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Surgical management of pulmonary hydatid cysts in children.

Authors:  M Elburjo; E A Gani
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.